Lumos Diagnostics Holdings Limited (LDXHF)
OTCMKTS · Delayed Price · Currency is USD
0.0768
-0.0241 (-23.85%)
Oct 6, 2025, 11:29 AM EDT
LDXHF Revenue
In the fiscal year ending June 30, 2025, Lumos Diagnostics Holdings had annual revenue of $12.40M with 11.40% growth. Lumos Diagnostics Holdings had revenue of $6.09M in the half year ending June 30, 2025, with 11.86% growth.
Revenue
12.40M
Revenue Growth
+11.40%
P/S Ratio
6.28
Revenue / Employee
n/a
Employees
n/a
Market Cap
77.86M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 12.40M | 1.27M | 11.40% |
| Jun 30, 2024 | 11.13M | 596.00K | 5.66% |
| Jun 30, 2023 | 10.54M | -1.10M | -9.42% |
| Jun 30, 2022 | 11.63M | -7.22M | -38.32% |
| Jun 30, 2021 | 18.85M | 13.06M | 225.25% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 105.45M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Jushi Holdings | 256.36M |
| Nuo Therapeutics | 1.95M |
Lumos Diagnostics Holdings News
- 4 weeks ago - Lumos Diagnostics Holdings Limited (LDXHF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 9 months ago - LH slashes new projects as economy slows - Bangkok Post
- 9 months ago - LH seen taking more cautious approach - Bangkok Post
- 9 months ago - Land & Houses seen taking more cautious approach - Bangkok Post